The combination of immune checkpoint inhibitor and chemotherapy may be efficacious for advanced non-small cell lung cancer with near-loop insertions of exon 20: A retrospective analysis

Objective The sensitivity of immune checkpoint inhibitors (ICIs) as monotherapy is low in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor ( EGFR ) exon 20 insertion mutations (ex20ins). This study aims at investigating the effectiveness of the combination of ICI and...

Description complète

Détails bibliographiques

Auteurs principaux:	Ke-Jun Liu, Hong-Rui Li, Quan-Quan Tan, Tao Jiang, Kai-Cheng Peng, Hua-Jun Chen, Qing Zhou, Xu-Chao Zhang, Zheng Zheng, Shi-Yuan Chen, Xue Zheng, Hong-Bo Zheng, Bei-Bei Mao, Long-Long Gong, Xian-Wen Chen, Wendy Wu, Yi-Long Wu, Jun Jia, Jin-Ji Yang
Format:	Artigo
Langue:	Inglês
Publié:	SAGE Publishing 2025-01-01
Collection:	Science Progress
Accès en ligne:	https://doi.org/10.1177/00368504251325406
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!